R E A Holdings PLC
LSE:RE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R E A Holdings PLC
LSE:RE
|
UK |
|
CNS Pharmaceuticals Inc
NASDAQ:CNSP
|
US |
|
D
|
Dermapharm Holding SE
DUS:DMP
|
DE |
|
Obic Business Consultants Co Ltd
TSE:4733
|
JP |
Wall St Price Targets
RE Price Targets Summary
R E A Holdings PLC
According to Wall Street analysts, the average 1-year price target for RE is 249.9 GBX with a low forecast of 207.05 GBX and a high forecast of 283.5 GBX.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RE's stock price target?
Price Target
249.9
GBX
According to Wall Street analysts, the average 1-year price target for RE is 249.9 GBX with a low forecast of 207.05 GBX and a high forecast of 283.5 GBX.
What is the Revenue forecast for R E A Holdings PLC?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for R E A Holdings PLC?
Projected CAGR
-19%
Over the last 14 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 8 years is -19%.
What is the Operating Income forecast for R E A Holdings PLC?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 3 years is 15%.
What is the Pre-Tax Income forecast for R E A Holdings PLC?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -7%. The projected CAGR for the next 3 years is 21%.
